enVVeno Medical Corp cotiza a 8.15 USD y tiene una capitalización bursátil de $6M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous …
| Periodo | 2026-07 | 2026-05 | 2025-07 | 2025-04 |
|---|---|---|---|---|
| Real | $-5.37 | $-5.89 | $-11.55 | $-7.70 |
| Estimado | $-4.69 | $-8.40 | $-9.80 | $-11.90 |
| Sorpresa | -14.5% | +29.9% | -17.9% | +35.3% |
| Métrica | NVNO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -71.8% | -40.4% | -31.4% |
| ROA | -65.9% | -32.0% | -33.9% |
| Current Ratio | 13.58 | 2.84 | +10.74 |
| Debt / Equity | — | 0.28 | — |